Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Fahrig, R; Quietzsch, D; Heinrich, JC; Heinemann, V; Boeck, S; Schmid, RM; Praha, C; Liebert, A; Sonntag, D; Krupitza, G; Hänel, M 
Titel:
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. 
Abstract:
RP101 [(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU)], which supports apoptosis and prevents the acquisition of chemoresistance, was tested in cultured human pancreatic tumor cells. RP101 downregulated uridine phosphorylase, a marker of poor prognosis, and APEX1, which is involved in DNA repair, and repressed Stat3 and its target vascular endothelial growth factor. Furthermore, RP101 activated antitumor immunity as demonstrated by enhanced cytolytic activity of NK-92 natural killer cells. This was...    »
 
Zeitschriftentitel:
Anticancer Drugs 
Jahr:
2006 
Band / Volume:
17 
Heft / Issue:
Seitenangaben Beitrag:
1045-56 
Sprache:
eng 
Print-ISSN:
0959-4973 
TUM Einrichtung:
II. Medizinische Klinik und Poliklinik